Autophagy in lysosomal myopathies

Brain Pathology

Volumn 22, Issue 1, 2012, Pages 82-88

  Malicdan, May Christine V ^a,b   Nishino, Ichizo ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

autophagy; Danon disease; LAMP 2; lysosome; myopathy; Pompe disease

Indexed keywords

AUTOPHAGY; CLINICAL FEATURE; CONFERENCE PAPER; DANON DISEASE; DISEASE COURSE; ENZYME REPLACEMENT; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LYSOSOMAL MYOPATHY; LYSOSOME; MYOPATHY; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOGENESIS;

ANIMALS; AUTOPHAGY; GLYCOGEN STORAGE DISEASE TYPE II; GLYCOGEN STORAGE DISEASE TYPE IIB; HUMANS; LYSOSOMES; MUSCLE, STRIATED; MYOSITIS;

EID: 83455243361     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00543.x     Document Type: Conference Paper

References (52)

1. Akanas V, Engel WK, (2006) Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 66: S39-S48.
2. Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, et al, (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3: 132-138.
3. Ballabio A, Gieselmann V, (2009) Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta 1793: 684-696.
4. Brech A, Ahlquist T, Lothe RA, Stenmark H, (2009) Autophagy in tumour suppression and promotion. Mol Oncol 3: 366-375.
5. Chu CT, (2006) Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol 65: 423-432. (Pubitemid 44297264)
6. Chu CT, Zhu J, Dagda R, (2007) Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy 3: 663-666. (Pubitemid 350060074)
7. Danon MJ, (1981) Lysosomal glycogen storage disease with normal acidic maltase. Neurology 31: 51-57. (Pubitemid 11217453)
8. Di Rocco M, Buzzi D, Tarò M, (2007) Glycogen storage disease type II: clinical overview. Acta Myol 26: 42-44. (Pubitemid 47400723)
9. Dice JF, (2007) Chaperone-mediated autophagy. Autophagy 3: 295-299. (Pubitemid 46986334)
10. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J, Von Figura K, Saftig P, (2002) Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 13: 3355-3368. (Pubitemid 35034269)
11. Eskelinen EL, Tanaka Y, Saftig P, (2003) At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13: 137-145. (Pubitemid 36293786)
12. Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, et al, (2004) Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 15: 3132-3145. (Pubitemid 38850111)
13. Fukuda T, Ahearn M, Roberts A, Mattaliano RJ, Zaal K, Ralston E, et al, (2006) Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther 14: 831-839. (Pubitemid 44743133)
14. Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N, (2006) Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 59: 700-708.
15. Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH, Raben N, (2006) Autophagy and lysosomes in Pompe disease. Autophagy 2: 318-320. (Pubitemid 44342381)
16. Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, Van der Ploeg AT, (2005) Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 128: 671-677. (Pubitemid 40380201)
17. Hesselink RP, Waggenmakers AJM, Drost MR, Van der Vusse GJ, (2003) Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II. Biochem Biophys Acta 1637: 164-170. (Pubitemid 36287411)
18. Hirschhorn R, Reuser AJ, (2001) Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: The Metabolic and Molecular Bases of Inherited Disease., CRBA Scriver, WS Sly, D Valle, (eds), pp. 3389-3420. McGraw-Hill: New York.
19. Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S, (2007) LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J 26: 313-324. (Pubitemid 46160933)
20. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al, (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
21. Kaneda D, Sugie K, Yamamoto A, Matsumoto H, Kato T, Nonaka I, Nishino I, (2003) A novel form of autophagic vacuolar myopathy with late-onset and multiorgan involvement. Neurology 61: 128-131. (Pubitemid 36818765)
22. Kishnani PS, Corzo D, Nicolino M Byrne B, Mandel H, Hwu WL, Leslie N, et al, (2007) Recombinant human (alpha)-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68: 99-109. (Pubitemid 46071892)
23. Kurz T, Terman A, Gustafson B, Brunk UT, (2008) Lysosomes and oxidative stress in ageing and apoptosis. Biochim Biophys Acta 1780: 1291-1303.
24. Malicdan MC, Noguchi S, Nishino I, (2007) Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Autophagy 3: 396-398. (Pubitemid 46986355)
25. Massey AC, Zhang C, Cuervo AM, (2006) Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 73: 205-235. (Pubitemid 43878134)
26. Mizushima N, (2007) Autophagy: process and function. Genes Dev 21: 2861-2873. (Pubitemid 350133435)
27. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y, (2004) In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15: 1101-1111. (Pubitemid 38316219)
28. Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, et al, (2009) Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med 11: 210-219.
29. Nishino I, (2003) Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep 3: 64-69. (Pubitemid 38898985)
30. Nishino I, (2006) Autophagic vacuolar myopathy. Semin Pediatr Neurol 13: 90-95. (Pubitemid 44486823)
31. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, et al, (2000) Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906-910. (Pubitemid 30664268)
32. Nishino I, Malicdan MC, Murayama K, Nonaka I, Hayashi YK, Noguchi S, (2005) Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol 24: 80-83. (Pubitemid 43287341)
33. Nonaka I, Sunohara N, Ishiura S, Satoyoshi E, (1981) Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci 51: 141-155. (Pubitemid 11078511)
34. Prall FR, Drack A, Taylor M, Ku L, Olson JL, Gregory D, et al, (2006) Ophthalmic manifestations of Danon disease. Ophthalmology 113: 1010-1013. (Pubitemid 43795242)
35. Raben N, Jatkar T, Lee A, Lu N, Dwivedi S, Nagaraju K, Glycogen PPH, (2002) stored in skeletal muscle but not in cardiac muscle in acid alpha glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme. Mol Ther 6: 601-608. (Pubitemid 35363692)
36. Raben N, Plotz PH, Byrne BJ, (2002) Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2: 145-166. (Pubitemid 34649837)
37. Raben N, Takikita S, Pittis MG, Bembi B, Marie SK, Roberts A, et al, (2007) Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand. Autophagy 3: 546-552. (Pubitemid 350060050)
38. Raben N, Hill V, Shea L, Takikita S, Baum R, Suppression MN, (2008) of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet 17: 3897-3908. (Pubitemid 352762852)
39. Raben N, Shea L, Hill V, Plotz PH, (2009) Monitoring autophagy in lysosomal storage disorders. Methods Enzymol 453: 417-449.
40. Raben N, Schreiner C, Baum R, Takikita S, Xu S, Xie T, et al, (2010) Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompei disease. Autophagy 6: 1078-1089.
41. Schorderet DF, Cottet S, Lobrinus JA, Borruat FX, Balmer A, Munier FL, (2007) Retinopathy in Danon disease. Arch Ophthalmol 125: 231-236.
42. Shintani T, Klionsky DJ, (2004) Autophagy in health and disease: a double-edged sword. Science 306: 990-995. (Pubitemid 39482894)
43. Smith J, Zellweger H, Afifi AK, (1967) Muscular form of glycogenosis, type II (Pompe). Neurology 17: 537-549.
44. Stypmann J, Janssen PM, Prestle J, Engelen MA, Kögler H, Lüllmann-Rauch R, et al, (2006) LAMP-2 deficient mice show depressed cardiac contractile function without significant changes in calcium handling. Basic Res Cardiol 101: 281-291. (Pubitemid 43923384)
45. Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, et al, (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology 58: 1773-1778. (Pubitemid 34663577)
46. Sugie K, Noguchi S, Kozuka Y, Arikawa-Hirasawa E, Tanaka M, Yan C, et al, (2005) Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol 64: 513-522. (Pubitemid 40781154)
47. Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lüllmann-Rauch R, et al, (2000) Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406: 902-906. (Pubitemid 30664267)
48. Wang CW, Klionsky DJ, (2003) The molecular mechanism of autophagy. Mol Med 9: 65-76. (Pubitemid 36819962)
49. Wu JJ, Quijano C, Chen E, Liu H, Cao L, Fergusson MM, (2009) Mitochondrial dysfunction and oxidative stress mediate the physiologic impairment induced by the disruption of autophagy. Aging (Albany NY) 1: 425-437.
50. Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L, (2009) Abberant α-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 4: e5515.
51. Yan C, Tanaka M, Sugie K, et al, (2005) A new congenital form of X-linked autophagic vacuolar myopathy. Neurology 65: 1132-1134. (Pubitemid 41429652)
52. Yorimitsu T, Klionsky DJ, (2005) Autophagy: molecular machinery for self-eating. Cell Death Differ 12 (Suppl. 2): 1542-1552. (Pubitemid 41553991)